Exact Mass: 254.0855704
Exact Mass Matches: 254.0855704
Found 500 metabolites which its exact mass value is equals to given mass value 254.0855704,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ketoprofen
Ketoprofen is only found in individuals that have used or taken this drug. It is a propionic acid derivative and is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties. The anti-inflammatory effects of ketoprofen are believed to be due to inhibition cylooxygenase-2 (COX-2), an enzyme involved in prostaglandin synthesis via the arachidonic acid pathway. This results in decreased levels of prostaglandins that mediate pain, fever and inflammation. Ketoprofen is a non-specific cyclooxygenase inhibitor and inhibition of COX-1 is thought to confer some of its side effects, such as GI upset and ulceration. Ketoprofen is thought to have anti-bradykinin activity, as well as lysosomal membrane-stabilizing action. Antipyretic effects may be due to action on the hypothalamus, resulting in an increased peripheral blood flow, vasodilation, and subsequent heat dissipation. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 205 CONFIDENCE standard compound; INTERNAL_ID 1150 CONFIDENCE standard compound; INTERNAL_ID 4086 CONFIDENCE standard compound; INTERNAL_ID 8562 D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Dyphylline
Dyphylline is only found in individuals that have used or taken this drug. It is a theophylline derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis. [PubChem]The bronchodilatory action of dyphylline, as with other xanthines, is thought to be mediated through competitive inhibition of phosphodiesterase with a resulting increase in cyclic AMP producing relaxation of bronchial smooth muscle as well as antagonism of adenosine receptors. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor KEIO_ID D183; [MS2] KO008931 KEIO_ID D183 Diphylline (Diprophylline) is a potent A1/A2 adenosine receptor antagonist and cyclic nucleotide phosphodiesterase inhibitor. Diphylline, a xanthine derivative, is a bronchodilator and vasodilator agent and has the potential for chronic bronchitis and emphysema[1][2]. Diphylline (Diprophylline) is a potent A1/A2 adenosine receptor antagonist and cyclic nucleotide phosphodiesterase inhibitor. Diphylline, a xanthine derivative, is a bronchodilator and vasodilator agent and has the potential for chronic bronchitis and emphysema[1][2].
L-Phosphoarginine
L-Phosphoarginine is found in crustaceans. L-Phosphoarginine is a constituent of crayfish muscle KEIO_ID P105
Chalepensin
D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents > D011564 - Furocoumarins
Galactosylglycerol
Galactosylglycerol is an intermediate in galactose and glycerolipid metabolism (KEGG: C05401). In galactose metabolism, galactosylglycerol is reversibly produced from D-galactose and glycerol by the enzyme alpha-galactosidase [EC:3.2.1.22]. It is also the first to last step in the synthesis of glycerol and is converted from 1,2-diacyl-3-beta-D-galactosyl-sn-glycerol. It is then converted to glycerol via the enzyme beta-galactosidase [EC:3.2.1.23]. [HMDB] Galactosylglycerol is an intermediate in galactose and glycerolipid metabolism (KEGG: C05401). In galactose metabolism, galactosylglycerol is reversibly produced from D-galactose and glycerol by the enzyme alpha-galactosidase [EC:3.2.1.22]. It is also the first to last step in the synthesis of glycerol and is converted from 1,2-diacyl-3-beta-D-galactosyl-sn-glycerol. It is then converted to glycerol via the enzyme beta-galactosidase [EC:3.2.1.23].
2-Hydroxyfelbamate
C11H14N2O5 (254.09026740000002)
2-Hydroxyfelbamate is a metabolite of felbamate. Felbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy. (Wikipedia)
p-Hydroxyfelbamate
C11H14N2O5 (254.09026740000002)
p-Hydroxyfelbamate is a metabolite of felbamate. Felbamate (marketed under the brand name Felbatol by MedPointe) is an anti-epileptic drug used in the treatment of epilepsy. It is used to treat partial seizures (with and without generalization) in adults and partial and generalized seizures associated with Lennox-Gastaut syndrome in children. However, an increased risk of potentially fatal aplastic anemia and/or liver failure limit the drugs usage to severe refractory epilepsy. (Wikipedia)
Isopropylthioxanthone
CONFIDENCE standard compound; INTERNAL_ID 4181
1-(2-hydroxy-4-methoxyphenyl)-3-phenylprop-2-en-1-one
3-(2-hydroxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
L-Agaridoxin
C11H14N2O5 (254.09026740000002)
L-Agaridoxin is found in mushrooms. L-Agaridoxin is a constituent of Agaricus campestris (field mushroom)
3,6-Dimethoxy-4-phenanthrenol
3,6-Dimethoxy-4-phenanthrenol is found in opium poppy. 3,6-Dimethoxy-4-phenanthrenol is found in opiu
2,6-Dimethoxy-4-phenanthrenol
2,6-Dimethoxy-4-phenanthrenol is found in poppy seeds, opium poppy and opium extracts. Found in opium extracts
(2R)-1-O-beta-D-Galactopyranosylglycerol
(2R)-1-O-beta-D-Galactopyranosylglycerol is found in cereals and cereal products. (2R)-1-O-beta-D-Galactopyranosylglycerol is isolated from wheat flour lipids. Isolated from wheat flour lipids. (2R)-1-O-beta-D-Galactopyranosylglycerol is found in cereals and cereal products.
Dexketoprofen
Dexketoprofen belongs to a class of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the action of a substance in the body called cyclo-oxygenase. Cyclo-oxygenase is involved in the production of chemicals in the body called prostaglandins. Prostaglandins are produced in response to injury or certain diseases and would otherwise go on to cause swelling, inflammation and pain. By blocking cyclo-oxygenase, dexketoprofen prevents the production of prostaglandins and therefore reduces inflammation and pain. Along with Peripheral analgesic action it possesses central analgesic action. Dexketoprofen is a non-steroidal anti-inflammatory drug. It is manufactured by Menarini, under the tradename Keral. It is available in the UK, as dexketoprofen trometamol, as a prescription-only drug and in Latin America as Miracox, produced by Stein in Costa Rica. In Italy it is available as an over the counter-drug under the tradename Enantyum. In Lithuania it is available as over the counter-drug uder tradename Dolmen. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Acetaminophen cystein
Acetaminophen cystein is a metabolite of acetaminophen.
2-Acetylaminophenoxazin-3-one
2-Acetylaminophenoxazin-3-one (AAPO) is a benzoxazinoid metabolite. It was found excreted in the feces of rats that were fed a rye bread-based diet which makes this compound a potential fecal biomarker of whole grain intake (PMID: 23113707).
Butanoic acid, [(diethoxyphosphinyl)oxy]methyl ester
Fenbufen
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Indolocarbazole
3-beta-D-galactosyl-sn-glycerol
3-beta-d-galactosyl-sn-glycerol is a member of the class of compounds known as glycosylglycerols. Glycosylglycerols are glycerolipids structurally characterized by the presence of one or more sugar residues attached to glycerol via a glycosidic linkage. 3-beta-d-galactosyl-sn-glycerol is soluble (in water) and a very weakly acidic compound (based on its pKa). 3-beta-d-galactosyl-sn-glycerol can be found in a number of food items such as skunk currant, european chestnut, oval-leaf huckleberry, and coriander, which makes 3-beta-d-galactosyl-sn-glycerol a potential biomarker for the consumption of these food products. 3-β-d-galactosyl-sn-glycerol is a member of the class of compounds known as glycosylglycerols. Glycosylglycerols are glycerolipids structurally characterized by the presence of one or more sugar residues attached to glycerol via a glycosidic linkage. 3-β-d-galactosyl-sn-glycerol is soluble (in water) and a very weakly acidic compound (based on its pKa). 3-β-d-galactosyl-sn-glycerol can be found in a number of food items such as skunk currant, european chestnut, oval-leaf huckleberry, and coriander, which makes 3-β-d-galactosyl-sn-glycerol a potential biomarker for the consumption of these food products.
fenbufen
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
2-Isopropyltioxanthone
CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10555; ORIGINAL_PRECURSOR_SCAN_NO 10552 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10557; ORIGINAL_PRECURSOR_SCAN_NO 10552 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10555; ORIGINAL_PRECURSOR_SCAN_NO 10550 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10599; ORIGINAL_PRECURSOR_SCAN_NO 10598 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10624; ORIGINAL_PRECURSOR_SCAN_NO 10623 CONFIDENCE standard compound; INTERNAL_ID 1081; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10619; ORIGINAL_PRECURSOR_SCAN_NO 10616 CONFIDENCE standard compound; INTERNAL_ID 2465 CONFIDENCE standard compound; INTERNAL_ID 8800 CONFIDENCE standard compound; INTERNAL_ID 8204
2-{[1-Cyano-2-(dimethylamino)vinyl]sulfonyl}-3-(dimethylamino)acrylonitrile
5-Methoxyflavanone
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.122 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.121
4-methoxy-3-methylnaphto[1,2-b]oxepin-2(3H)-one|aggregatin B
(3R,4R)-3,4-dihydro-4,8-dihydroxy-6,7-dimethoxy-3-methylisocoumarin|3,4-Dihydro-4,8-dihydroxy-6,7-dimethoxy-3-methyl-1H-2-benzopyran-1-one
4-Acetoxy-3,5-dimethoxy-benzoesaeure-methylester|4-acetoxy-3,5-dimethoxy-benzoic acid methyl ester|Acetylsyringasaeure-methylester|AMS|methyl 4-acetoxy-3,5-dimethoxybenzoate|methyl 4-acetyl syringate
Me ether-2,3-Dihydro-3-hydroxy-2-phenyl-4H-1-benzopyran-4-one
9-methyl-6a,11a-dihydro-6H-benzofuro[3,2-c]chromen-3-ol
4-[4-hydroxy-3-methoxyphenyl]-indan-1-one|afzeliindanone
9H-Pyrido(3,4-b)indole-3-carboxylic acid, 1-acetyl-
3-O-Methylcyclopolsaeure|3-O-Metyl-cyclopolsaeure|Me ether-Cyclopolic acid
methyl (2Z,4E)-6(acetyloxy)-5-formyl-7-oxoocta-2,4-dienoate
4-(2,3-dihydroxy-5-methoxy-4-methylphenyl)-4-oxobutanoic acid
2,7-dihydroxy-1-methyl-5-aldehyde-9,10-dihydrophenanthrene|2,7-dihydroxy-1-methyl-9,10-dihydrophenanthrene-5-carbaldehyde
3-Ethoxycarbonyl-2-hydroxy-6-methoxy-4-methylbenzoic acid
3-Hydroxy-5-methoxy-benzalacetophenon|3-hydroxy-5-methoxybenzalacetophenone
(3R*,4S*)-3,4-dihydro-3,4,8-trihydroxy-3-(hydroxymethyl)-6-methoxynaphthalen-1(2H)-one|balticol C
1,12-diacetoxy-7-phenylhept-2c-ene-4,6-diyne|3-Me ether,1-Ac-(Z)-7-(3-Hydroxyphenyl)-2-phenyl-4,6-diyn-1-ol
2-Formyl-azobenzol-carbonsaeure-(2)|2-(2-Formyl-phenylazo)-benzoesaeure|2-(2-formyl-phenylazo)-benzoic acid|Benzaldehyd-(2 azo 2)-benzoesaeure
5-hydroxymethyl-2-(4-hydroxyphenyl)-3-methylbenzofuran
(5S,7S)-7-acetoxy-5,10-dihyroxy-Delta8,9dolichodial|jatamanin M
D-Isofloridoside
3-O-alpha-D-galactosyl-sn-glycerol is a isofloridoside in which position 2 of the glyceryl moiety has R configuration.
ketoprofen
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors relative retention time with respect to 9-anthracene Carboxylic Acid is 1.070 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.068 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.071
6-(2-methylbut-3-en-2-yl)furo[3,2-g]chromen-7-one
6-methoxy-2-phenyl-2,3-dihydrochromen-4-one
2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one
(4S,5Z,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid
Diprophylline
Diphylline (Diprophylline) is a potent A1/A2 adenosine receptor antagonist and cyclic nucleotide phosphodiesterase inhibitor. Diphylline, a xanthine derivative, is a bronchodilator and vasodilator agent and has the potential for chronic bronchitis and emphysema[1][2]. Diphylline (Diprophylline) is a potent A1/A2 adenosine receptor antagonist and cyclic nucleotide phosphodiesterase inhibitor. Diphylline, a xanthine derivative, is a bronchodilator and vasodilator agent and has the potential for chronic bronchitis and emphysema[1][2].
L-Agaridoxin
C11H14N2O5 (254.09026740000002)
Dexketoprofen
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
3-Ethyl-5-[2-(3-methyloxazolidin-2-ylidene)ethylidene]-2-thioxooxazolidin-4-one
2-(3-(METHYLAMINO)PROPYL)ISOINDOLINE-1,3-DIONE HYDROCHLORIDE
3-methyl-N-(4-methylphenyl)-1,3-benzothiazol-2-imine
2-(6-oxocyclohexa-2,4-dien-1-ylidene)-1,3-dihydrobenzimidazole-4-carboxylic acid
2-Propen-1-one,1-(2-hydroxyphenyl)-3-(3-methoxyphenyl)-
sulfadicramide
S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AB - Sulfonamides C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent
Phenol,2-(1-methylbutyl)-4,6-dinitro-
C11H14N2O5 (254.09026740000002)
3-(PIPERIDIN-4-YL)BENZO[D]OXAZOL-2(3H)-ONE HYDROCHLORIDE
Dimethyl 2,5-dioxobicyclo[2.2.2]octane-1,4-dicarboxylate
4-chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
4-[5-(4-oxocyclohexa-2,5-dien-1-ylidene)-1,3,4-oxadiazolidin-2-ylidene]cyclohexa-2,5-dien-1-one
1h-indol-3-ylmethylamine oxalate hemihydrate
C11H14N2O5 (254.09026740000002)
(S)-Methyl 3-aMino-2-((tert-butoxycarbonyl)aMino)propanoate hydrochloride
C9H19ClN2O4 (254.10332839999998)
N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)METHACRYLAMIDE
C12H9F3N2O (254.06669399999998)
2-DEOXY-2,2-DIFLUORO-4,5-O-(1-METHYLETHYLIDENE)-L-ERYTHRO-PENTONIC ACID, ETHYL ESTER
C10H16F2O5 (254.09657499999997)
4-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
Methyl 2-(pyridin-4-yl)benzo[d]oxazole-7-carboxylate
(6-CHLOROPYRIDAZIN-3-YL)(4-ETHYLPIPERAZIN-1-YL)METHANONE
C11H15ClN4O (254.09343299999998)
3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
5-Fluoro-2-[(4-methoxyphenyl)ethynyl]benzaldehyde
C16H11FO2 (254.07430380000002)
5-(2-FURYL)-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID
2-(1,3-benzodioxol-5-yl)imidazo[1,2-a]pyrimidin-3-amine
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylic acid
1-(TERT-BUTYL)-5-(2,4,5-TRIFLUOROPHENYL)-1H-PYRAZOLE
C13H13F3N2 (254.10307740000002)
6,6,6-TRIFLUORO-3,5-DIOXO-HEXANOIC ACID, 1,1-DIMETHYLETHYL ESTER
C10H13F3O4 (254.07658940000002)
1-acetyl-5(3)-phenyl-3(5)-(trifluoromethyl)pyrazole
C12H9F3N2O (254.06669399999998)
2-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine
2-(3-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
2,4-DIHYDRO-5-(4-FLUOROPHENYL)-2-PHENYL-3H-PYRAZOL-3-ONE
3-chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine
(7R)-2-Chloro-7-ethyl-7,8-dihydro-8-(1-methylethyl)-6(5H)-pteridinone
C11H15ClN4O (254.09343299999998)
4-(3-FLUOROPHENYL)-7-METHYL-2H-CHROMEN-2-ONE
C16H11FO2 (254.07430380000002)
potassium,1,2-bis(ethenyl)benzene,2-methylprop-2-enoate
3-Chloro-4-hydroxyphenylboronic acid, pinacol ester
phenobarbital sodium
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C67084 - Barbiturate D065693 - Cytochrome P-450 Enzyme Inducers > D065695 - Cytochrome P-450 CYP2B6 Inducers D065693 - Cytochrome P-450 Enzyme Inducers > D065701 - Cytochrome P-450 CYP3A Inducers D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
7-Methyl-1-phenyl-1H-pyrido[2,3-d][1,3]oxazine-2,4-dione
ethyl 2-methyl-2-(2-methyl-4-sulfanyl-phenoxy)propanoate
Methyl 3-methoxy-2-(2-methoxy-2-oxoethoxy)benzoate
4-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
ETHYL (2E)-3-[4-[AMINO(IMINO)METHYL]PHENYL]ACRYLATE HYDROCHLORIDE
2-[1-Methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzaldehyde
C12H9F3N2O (254.06669399999998)
4-[2-(trifluoromethyl)pyridin-4-yl]oxyaniline
C12H9F3N2O (254.06669399999998)
6-FLUORO-4-METHYL-3-PHENYLCOUMARIN
C16H11FO2 (254.07430380000002)
3,4-dihydro-2h-1,5-benzodioxepin-7-yl(phenyl)methanone
3-[[(1,1-Dimethylethoxy)carbonyl]amino]-D-alanine methyl ester
C9H19ClN2O4 (254.10332839999998)
2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-4-CARBOXYLIC ACID
2-Chloro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-amine
4-Fluoro-2-[(4-methoxyphenyl)ethynyl]benzaldehyde
C16H11FO2 (254.07430380000002)
2-Chloro-1-(3-Methyl-2,3,5,6-tetrahydro-[1,2]bipyrazinyl-4-yl)-ethanone
C11H15ClN4O (254.09343299999998)
Purine-9-beta-D-(2-deoxy-2-fluoro) arabinoriboside
2-Propen-1-one,3-(4-hydroxyphenyl)-1-(4-methoxyphenyl)-
2-CHLORO-3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOL
2-(2-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
2,8-Diazaspiro[4.5]decane, 8-(methylsulfonyl)-, hydrochloride (1:1)
5-(TERT-BUTYL)-2-METHOXY-1,3-DINITROBENZENE
C11H14N2O5 (254.09026740000002)
Ethyl (3R,S)-2,2-difluoro-3-hydroxy-3-(2,2-dimethyldioxolan-4-yl)propionate
C10H16F2O5 (254.09657499999997)
3-Chloro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
8-(Trifluoromethyl)-2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one
C12H9F3N2O (254.06669399999998)
3-(4-Chlorophenyl)-3-oxetaneacetic acid ethyl ester
2-HYDROXY-5-IMIDAZO[1,2-A]PYRIMIDIN-2-YL-BENZAMIDE
1-(2-Hydroxy-5-methylphenyl)-3-phenylpropane-1,3-dione
2-(4-HYDROXY-PHENYL)-3H-BENZOIMIDAZOLE-5-CARBOXYLIC ACID
3-[METHOXY(METHYL)CARBAMOYL]-5-NITROPHENYLBORONIC ACID
C9H11BN2O6 (254.07101360000001)
2-fluoro-2-[4-[(2-methylpropan-2-yl)oxycarbonyl]phenyl]acetic acid
C13H15FO4 (254.09543219999998)
Phenol,4-(1,1-dimethylpropyl)-2,6-dinitro-
C11H14N2O5 (254.09026740000002)
6-FLUORO-3-(PIPERIDIN-4-YL)-1H-INDOLE HYDROCHLORIDE
N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide
C11H14N2O5 (254.09026740000002)
2-O-(beta-D-glucosyl)glycerol
A glucosylglycerol consisting of a beta-D-glucosyl residue attached at position 2 of glycerol via a glycosidic bond.
2-Amino-7,10-dimethyl-dibenz(b,f)(1,4)oxazepin-11-(10H)-one
7-[(2S)-2,3-dihydroxypropyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
(2S)-5-amino-2-(3,4-dihydroxyanilino)-5-oxopentanoic acid
C11H14N2O5 (254.09026740000002)
2,2,2-trifluoro-N-(2-methyl-8-quinolinyl)acetamide
C12H9F3N2O (254.06669399999998)
N-{4-[(2-hydroxybenzylidene)amino]phenyl}acetamide
N-(3-hydroxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide
2-[[4-Chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino]-2-methylbutanenitrile
Trimethylsilyl 3,4-dimethoxybenzoate
C12H18O4Si (254.09743079999998)
Methyl 3-methoxy-4-[(trimethylsilyl)oxy]benzoate
C12H18O4Si (254.09743079999998)
1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 1-oxo-, methyl ester
Methyl 4-methoxy-3-trimethylsilyloxybenzoate
C12H18O4Si (254.09743079999998)
2-(2-Oxo-1,2-dihydro-pyridin-3-yl)-1h-benzoimidazole-5-carboxamidine
C13H12N5O+ (254.10418019999997)
(2S)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile
(2R)-2-{[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino}-2-methylbutanenitrile
2-(2-Aminopropanoylamino)-2-phenylsulfanylacetic acid
5,6-Dimethyl-3-[5-(trifluoromethyl)pyridin-2-yl]-1,2,4-triazine
(1S,2R,3R,4R,5S)-5-[(2S)-2,3-dihydroxypropoxy]-1-(hydroxymethyl)cyclopentane-1,2,3,4-tetrol
3-(4,7-Dimethoxy-1,3-benzodioxol-5-yl)propanoic acid
6-[(3-hydroxypropyl)amino]-5-[(E)-(2-oxopropylidene)amino]pyrimidine-2,4(1H,3H)-dione
3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)propanoic acid
3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)-2-hydroxypropanal
[3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)oxiran-2-yl]methanol
3-(6-Hydroxy-2,3,4-trimethoxyphenyl)prop-2-enoic acid
3-(6,7-Dimethoxy-1,3-benzodioxol-5-yl)-3-hydroxypropanal
3,5-Dimethoxy-4-[(trimethylsilyl)oxy]benzaldehyde
C12H18O4Si (254.09743079999998)
Methyl 4-methoxysalicylate, TMS derivative
C12H18O4Si (254.09743079999998)
2,5-Dimethoxybenzoic acid, trimethylsilyl ester
C12H18O4Si (254.09743079999998)
dyphylline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor Diphylline (Diprophylline) is a potent A1/A2 adenosine receptor antagonist and cyclic nucleotide phosphodiesterase inhibitor. Diphylline, a xanthine derivative, is a bronchodilator and vasodilator agent and has the potential for chronic bronchitis and emphysema[1][2]. Diphylline (Diprophylline) is a potent A1/A2 adenosine receptor antagonist and cyclic nucleotide phosphodiesterase inhibitor. Diphylline, a xanthine derivative, is a bronchodilator and vasodilator agent and has the potential for chronic bronchitis and emphysema[1][2].
2-O-alpha-D-Glucosylglycerol
A glucosylglycerol consisting of an alpha-D-glucosyl residue attached at position 2 of glycerol via a glycosidic bond.
2-(2,3-dihydroxypropoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2R,3R,4S,5R,6R)-2-(2,3-dihydroxypropoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2-Amino-5-[[amino-(phosphonoamino)methylidene]amino]pentanoic acid
(R)-4-methoxydalbergione
A member of the class of 1,4-benzoquinones that is p-benzoquinone substituted by a methoxy group at position 2 and a 1-phenylallyl group at position 5. Isolated from the heartwood of Dalbergia louveli, it exhibits antiplasmodial activity.
N(Omega)-phospho-L-arginine
An arginine derivative that is L-arginine substituted by a phosphono group at N(omega)-position.
2,3-dihydroxypropyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
2-(4-hydroxy-5-methoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)ethyl acetate
2-methoxy-5-[(1s)-1-phenylprop-2-en-1-yl]cyclohexa-2,5-diene-1,4-dione
9-methoxy-3,8-dimethylnaphtho[2,3-b]furan-4-carbaldehyde
3-hydroxy-4-(4-hydroxy-3,5-dimethoxyphenyl)oxolan-2-one
(3r,4s)-4-hydroxyoxolan-3-yl 2,4-dihydroxy-6-methylbenzoate
(2s)-2-amino-4-[(3,4-dihydroxyphenyl)-c-hydroxycarbonimidoyl]butanoic acid
C11H14N2O5 (254.09026740000002)
3-hydroxy-5,7-dimethoxy-2-methyl-2,3-dihydro-1-benzofuran-6-carboxylic acid
(2r,3r,4s,5s,6s)-2-[(2s)-2,3-dihydroxypropoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
4,6,8-trihydroxy-3-methoxy-3,7-dimethyl-4h-2-benzopyran-1-one
14-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaen-5-ol
methyl (2z,4e,6s)-6-(acetyloxy)-5-formyl-7-oxoocta-2,4-dienoate
3-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1(10),2,4,6,14-pentaen-9-one
1-o-caffeoylglycerol
{"Ingredient_id": "HBIN002861","Ingredient_name": "1-o-caffeoylglycerol","Alias": "NA","Ingredient_formula": "C12H14O6","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OCC(CO)O)O)O","Ingredient_weight": "254.24 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2907","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5315606","DrugBank_id": "NA"}
1-o-caffoylglycerol
{"Ingredient_id": "HBIN002863","Ingredient_name": "1-o-caffoylglycerol","Alias": "NA","Ingredient_formula": "C12H14O6","Ingredient_Smile": "C1=CC(=C(C=C1C=CC(=O)OCC(CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30716","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-o-coumaroylglycerol; (s,e)-form,3'-hydroxy
{"Ingredient_id": "HBIN002869","Ingredient_name": "1-o-coumaroylglycerol; (s,e)-form,3'-hydroxy","Alias": "NA","Ingredient_formula": "C12H14O6","Ingredient_Smile": "NA","Ingredient_weight": "254.24","OB_score": "NA","CAS_id": "138812-55-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9139","PubChem_id": "NA","DrugBank_id": "NA"}
1-o-glucopyranosylglycerol; alpha-d-(2s)-form
{"Ingredient_id": "HBIN002915","Ingredient_name": "1-o-glucopyranosylglycerol; alpha-d-(2s)-form","Alias": "NA","Ingredient_formula": "C9H18O8","Ingredient_Smile": "NA","Ingredient_weight": "254.23","OB_score": "NA","CAS_id": "23202-75-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9127","PubChem_id": "NA","DrugBank_id": "NA"}
1-o-glucopyranosylglycerol; beta-d-(2r)-form
{"Ingredient_id": "HBIN002916","Ingredient_name": "1-o-glucopyranosylglycerol; beta-d-(2r)-form","Alias": "NA","Ingredient_formula": "C9H18O8","Ingredient_Smile": "NA","Ingredient_weight": "254.23","OB_score": "NA","CAS_id": "23202-73-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9126","PubChem_id": "NA","DrugBank_id": "NA"}
2-hydroxy-3,7-dimethoxyphenanthrene
{"Ingredient_id": "HBIN005740","Ingredient_name": "2-hydroxy-3,7-dimethoxyphenanthrene","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "COC1=CC2=C(C=C1)C3=CC(=C(C=C3C=C2)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10033","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-oxobicyclo(3. 2. 2)nona- 3,6- dien- 1- yl benzoate
{"Ingredient_id": "HBIN006279","Ingredient_name": "2-oxobicyclo(3. 2. 2)nona- 3,6- dien- 1- yl benzoate","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "C1CC2C=CC1C=C(C2=O)OC(=O)C3=CC=CC=C3","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41568","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2r)-1-o-glyceryl-β-d-galactoside
{"Ingredient_id": "HBIN006359","Ingredient_name": "(2r)-1-o-glyceryl-\u03b2-d-galactoside","Alias": "NA","Ingredient_formula": "C9H18O8","Ingredient_Smile": "C(C1C(C(C(C(O1)OCC(CO)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8812","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(7S,8R)-dihydrodehydrodiconiferylalcohol-4-O-(β-D-glucopyranoside
{"Ingredient_id": "HBIN013475","Ingredient_name": "(7S,8R)-dihydrodehydrodiconiferylalcohol-4-O-(\u03b2-D-glucopyranoside","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "CC1C(OC2=C1C=C(C=C2)C=O)C3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41995","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(7S,8R)-dlihydrodehydrodiconiferyl alcohol-9-o-bei-D-glucoside
{"Ingredient_id": "HBIN013476","Ingredient_name": "(7S,8R)-dlihydrodehydrodiconiferyl alcohol-9-o-bei-D-glucoside","Alias": "NA","Ingredient_formula": "C16H14O3","Ingredient_Smile": "CC1C(OC2=C1C=C(C=C2)C=O)C3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42857","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s,3r)-2-{[(3-amino-2-hydroxyphenyl)(hydroxy)methylidene]amino}-3-hydroxybutanoic acid
C11H14N2O5 (254.09026740000002)
2',5-dihydroxy-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2-carbaldehyde
4',6-dihydroxy-3'-(prop-2-en-1-yl)-[1,1'-biphenyl]-3-carbaldehyde
4-(3-carboxy-2-hydroxy-3-methylpropoxy)benzoic acid
(4e)-2-hydroxy-5-methoxy-4-[(2e)-3-phenylprop-2-en-1-ylidene]cyclohexa-2,5-dien-1-one
6-[(1r)-2,2-dimethylcyclopropyl]furo[3,2-g]chromen-7-one
3-(4-hydroxy-2-methoxyphenyl)-1-phenylprop-2-en-1-one
(1r,9s,16s)-9-methyl-15-oxatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-2(7),4,10,12-tetraene-3,6-dione
(2e)-3-(4-hydroxy-2-methoxyphenyl)-1-phenylprop-2-en-1-one
(1r,15s)-15-methyl-8,14-dioxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-2,4,6,9,11,13(17)-hexaen-3-ol
4,6,8-trihydroxy-3-(hydroxymethyl)-4,5-dimethyl-3h-2-benzopyran-1-one
5-(5-acetyl-4-hydroxy-6-oxopyran-2-yl)pentanoic acid
3-hydroxy-2-(1,2,3-trihydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carbaldehyde
(2s,3r,4s,5r,6r)-2-[(2s)-2,3-dihydroxypropoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,3s)-3-hydroxy-5,7-dimethoxy-2-methyl-2,3-dihydro-1-benzofuran-6-carboxylic acid
(2z)-7-(3-methoxyphenyl)hept-2-en-4,6-diyn-1-yl acetate
2-(1-methoxy-3-phenylprop-2-en-1-ylidene)-4-methylcyclopent-4-ene-1,3-dione
6-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-13-ol
(2r)-2-amino-3-{[(1z)-1-(hydroxyimino)-2-phenylethyl]sulfanyl}propanoic acid
5-[(1e)-2-(3-methoxyphenyl)ethenyl]-2h-1,3-benzodioxole
5-[2-(4-methoxyphenyl)ethenyl]-2h-1,3-benzodioxole
13-methoxy-2-oxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-6-ol
3-(11-hydroxyundec-2-en-5,7,9-triyn-1-yl)-5-methyl-5h-furan-2-one
2-methoxy-5-(1-phenylprop-2-en-1-yl)cyclohexa-2,5-diene-1,4-dione
1-(4-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
4-[(2r,3r)-3-carboxy-2-hydroxy-3-methylpropoxy]benzoic acid
(1r,10r)-14-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaen-5-ol
(2e)-2-[(2e)-1-methoxy-3-phenylprop-2-en-1-ylidene]-4-methylcyclopent-4-ene-1,3-dione
(4z)-2-hydroxy-5-methoxy-4-[(2e)-3-phenylprop-2-en-1-ylidene]cyclohexa-2,5-dien-1-one
(2s,3r,4s,5s,6r)-2-[(1,3-dihydroxypropan-2-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2e)-2-benzyl-3-(4-hydroxyphenyl)prop-2-enoic acid
4-(4-hydroxy-3-methoxyphenyl)-2,3-dihydroinden-1-one
(2r,3r,4s,5s,6r)-2-[(2r)-2,3-dihydroxypropoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 3-(2,4-dihydroxy-6-methylbenzoyloxy)propanoate
(3s,4r)-4,6,8-trihydroxy-3-(hydroxymethyl)-4,5-dimethyl-3h-2-benzopyran-1-one
(1s,2s,4r,8r,9r)-8-hydroxy-4,10,10-trimethyl-3,11,12,13-tetraoxatetracyclo[7.3.1.0¹,⁷.0²,⁴]tridec-6-en-5-one
3,4-dihydroxy-2-methyl-7-(3-methyloxiran-2-yl)-2h,3h,4h-pyrano[4,3-b]pyran-5-one
8-hydroxy-4,10,10-trimethyl-3,11,12,13-tetraoxatetracyclo[7.3.1.0¹,⁷.0²,⁴]tridec-6-en-5-one
(3r)-5-hydroxy-4-(hydroxymethyl)-3,7-dimethoxy-6-methyl-3h-2-benzofuran-1-one
14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaene
(2s,3s,4s)-3,4-dihydroxy-2-methyl-7-[(2r,3r)-3-methyloxiran-2-yl]-2h,3h,4h-pyrano[4,3-b]pyran-5-one
(2s,3r)-2-(4-hydroxyphenyl)-3-methyl-2,3-dihydro-1-benzofuran-5-carbaldehyde
5-(2,3-dihydroxypropoxy)-1-(hydroxymethyl)cyclopentane-1,2,3,4-tetrol
(2s,3s)-3-hydroxy-2-(1,2,3-trihydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-carbaldehyde
(2r,3r)-2-(4-hydroxyphenyl)-3-methyl-2,3-dihydro-1-benzofuran-5-carbaldehyde
(2s)-2-[(3,4-dihydroxyphenyl)amino]-4-(c-hydroxycarbonimidoyl)butanoic acid
C11H14N2O5 (254.09026740000002)
(2e)-1-(2-hydroxy-4-methoxyphenyl)-3-phenylprop-2-en-1-one
(2e)-1-(4-hydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
3-hydroxy-4-[4-(prop-2-en-1-yl)phenoxy]benzaldehyde
(12s,16r)-3-methyl-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹²,¹⁶]heptadeca-1(10),2,4,6,14-pentaen-9-one
2-(4-hydroxyphenyl)-3-methyl-2,3-dihydro-1-benzofuran-5-carbaldehyde
(1s,10s)-14-methoxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2,4,6,11,13,15-hexaene
5-hydroxy-4-(hydroxymethyl)-3,7-dimethoxy-6-methyl-3h-2-benzofuran-1-one
(5r)-3-[(2z)-11-hydroxyundec-2-en-5,7,9-triyn-1-yl]-5-methyl-5h-furan-2-one
(2s)-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
2-amino-4-[(3,4-dihydroxyphenyl)-c-hydroxycarbonimidoyl]butanoic acid
C11H14N2O5 (254.09026740000002)